Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

ESIC Medical College and Hospital, Faridabad announces Positive Results of a clinical study evaluating Nisarga Herbs’ Neem Capsules for Prevention of COVID-19

Published

on

 

ESIC Medical College and Hospital, Faridabad and Nisarga Biotech Pvt. Ltd today announced the final data from a pilot, double-blind, randomized, placebo-controlled trial studying prophylactic activity of a proprietary, patent-pending, Neem-leaf extract (Azadirachta Indica A. Juss) of Nisarga Biotech in healthcare personnel and relatives in daily contact with COVID-19 patients. The study was a planned collaboration of ESIC Medical College and Hospital, Faridabad & All India Institute of Ayurveda (AIIA), New Delhi, and was sponsored by Nisarga Biotech Pvt. Ltd, Satara, MS.

The study was conducted in 190 participants of aged 18-60 years at ESIC Medical College and Hospital, Faridabad, between August to December 2020 under the Principal Investigator Prof. (Dr.) Tanuja Nesari, MD, PhD, Director, AIIA & Co Investigator Dr. A. K Pandey ESIC Medical College & Hospital, Faridabad. The study was approved by the Institutional Ethics Committee and registered at Clinical Trial Registry of India (CTRI) and was conducted in accordance with Good Clinical Practice guidelines and according to all applicable local regulatory and ethical requirements.

Results demonstrated the probability of COVID-19 infection in participants receiving Neem capsules 50 mg twice a day for 28-days was reduced to less than half (a relative risk of 0.45) that of participants receiving the placebo, with the effectiveness of Neem capsules being around 55%. Biomarkers and Quality of life (QOL) remained stable in both groups.

Explaining the significance of the results, Dr. Anil Kumar Pandey, MD, Registrar, ESIC Medical College and Hospital, Faridabad, said, “Ayurveda has immense contribution in prophylaxis of various diseases. These study findings are a leap forward for prophylaxis against the COVID 19 specially when there is no specific treatment available for treatment of Covid-19 infection. I am sure it will work great as a preventive as well as additional protection even during the two doses of vaccination where chances of infection are there. Safety is another critical component for prophylactic measures, and we are encouraged to see that the Neem formulation studied in this study has a better and acceptable safety profile.”

“Despite a number of SARS-CoV-2 vaccines gaining marketing authorization, COVID-19 continues to spread, and the majority of Indian population still need effective prophylactic treatment. We are extremely pleased with the outcome of this trial which provides early indications of the potential role of a proprietary, neem-leaf extract from Nisarga Biotech for the prophylaxis of COVID-19,” said Dr. Asim Das, Dean, ESIC Medical College and Hospital.

Girish Soman, Founder and CEO of Nisarga Biotech Pvt. Ltd said, “Nisarga is the first manufacturer to conduct a double-blind placebo-controlled trial for prevention of Covid 19 with comparable efficacy to Vaccines. This is one of the first studies published in peer reviewed international journal in collaboration with two of India’s renowned Ayurveda and medical institutes – AIIA and ESIC Medical College and Hospital, Faridabad. Our Neem formulation has proven to be an effective antiviral in preventive use against COVID-19 with a preventive efficacy rate of 55%. With the second wave hitting the country, our neem formulation is a great alternative for prevention of COVID-19 till the vaccines are widely and easily available in the country.”

The study results have been published in PubMed indexed, peer reviewed journal “Alternative Therapies in Health and Medicine” one of the oldest professional medical journals that covers holistic, natural and alternative medical treatments, in USA and is available online at https://pubmed.ncbi.nlm.nih.gov/33891569/  More information on this clinical study can be found at Clinical Trial Registry of India (CTRI).http://ctri.nic.in. (CTRI/2020/07/026560)

Artificial Intelligence

Addverb Releases 2023 Sustainability Report Detailing Company’s Journey towards Technological Ecology

Published

on

addverb-releases-2023-sustainability-report-detailing-company’s-journey-towards-technological-ecology

Successfully achieving the FY22-23 Extended Producer Responsibility (EPR) target of 3 metric tonnesFulfilled 17% of energy demand from renewable sources in CY 2023Improvement of the power factor from 0.88 to 0.99 over two yearsNOIDA, India, April 30, 2024 /PRNewswire/ — Addverb, a global leader in robotics and automation, releases its first Sustainability Report titled ‘Technological Ecology’. The report is produced in accordance with GRI Universal Standards and incorporates Environment, Social, and Governance (ESG) factors underscoring Addverb’s unwavering dedication to sustainability and commitment. Reporting initiatives from January 1st to December 3st, 2023, the report showcases Addverb’s commitment to Technological Ecology, aiming to reduce ecological impact while contributing to the planet’s well-being.

The report can be accessed on the Company’s website.
Commenting on the release of the report, Mr. Sangeet Kumar, Co-founder and CEO, Addverb said, “Addverb harnesses solar energy, employs energy-efficient machinery, and integrates lean manufacturing practices to reduce Greenhouse gas (GHG) emissions and promote responsible power consumption. Our vision extends beyond product creation to embedding sustainability throughout our designs and manufacturing processes, focusing on ecological balance and technological advancements.”
Addverb is committed to mitigating environmental impact through proactive measures and innovation, including strategic tree-planting initiatives, green belt cultivation for ecological restoration, sustainable water management practices with a focus on groundwater recharge, and fostering an inclusive workplace environment through Diversity, Equity, and Inclusion (DEI) initiatives.
Addverb, through this report, reflects its unwavering dedication to sustainability, innovation, and responsible business practices. By prioritising environmental stewardship and social responsibility, the company continues to pave the way for a greener and a more sustainable future.
About Addverb
Founded in 2016, Addverb offers end-to-end robotics solutions for warehouses and industrial automation. Addverb is based in India, with R&D facilities in India and the US, and subsidiaries worldwide, including Australia, Singapore, the Netherlands, and the US. Its fleet of automated robots and material handling technologies, along with in-house system integration and software solutions, enhances warehouse operations’ efficiency and accuracy.
Addverb provides tailored automation solutions, with its self-manufactured products, and a wide range portfolio consisting of Autonomous Mobile Robots, Sorting Robots, Automated Storage and Retrieval Systems, and Picking Technologies, fuelled by enterprise software; with a range of 350+ customers like Coca-Cola, PepsiCo, Unilever, Reliance, DHL, Amazon, ITC to name a few.
For more information visit: www.addverb.com or connect on [email protected].  
Photo : https://mma.prnewswire.com/media/2399932/Bioretention_pond.jpg Logo : https://mma.prnewswire.com/media/2399931/Addverb_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/addverb-releases-2023-sustainability-report-detailing-companys-journey-towards-technological-ecology-302130075.html

Continue Reading

Artificial Intelligence

New Independent Study Shows 70% of Organizations Prioritize Gen AI for Boosting Employee Productivity

Published

on

new-independent-study-shows-70%-of-organizations-prioritize-gen-ai-for-boosting-employee-productivity

The exclusive study commissioned by Apexon reveals how organizations, particularly from more regulated industries, are seizing the GenAI advantageOver 50% of surveyed organizations are implementing Gen AI in their businessesSUNDERLAND, England, April 30, 2024 /PRNewswire/ —  Apexon, a digital-first technology services company, today unveiled key findings from a Forrester Opportunity Snapshot Study “Regulated Industries Are Making Generative AI Core to Their Digital Strategy.” The study commissioned by Apexon and conducted by Forrester Consulting highlights significant insights into the adoption, challenges, and future of Gen AI in highly regulated industries such as Financial Services, Healthcare and Life Sciences. A critical finding is that while organizational readiness may not impede Gen AI adoption, the absence of governance proves to be a significant barrier.

 
 
The study surveyed 125 US-based CXOs and key decision-makers responsible for AI strategy, representing organizations.
According to the findings, a significant 71% of organizations prefer to procure Gen AI solutions from technology vendors, underscoring the strategic shift towards leveraging external expertise for technological advancement. The findings also throw light on the transformative potential of Gen AI to enhance employee productivity and customer experience.
Key highlights from the study also include:
Enhancing employee productivity has emerged as the primary use case surpassing customer experience, traditionally the most prevalent industry use case. 70% of the surveyed organizations are directing their investments in Generative AI towards elevating employee efficiency for more impactful activities.Investments in building a strong Gen AI ecosystem are expected to increase significantly in 2025.Financial Services prioritize customer service improvements, while Healthcare Life Sciences focus on digital operations enhancement with Gen AI. “Generative AI is arguably the most disruptive technology, set to revolutionize industries and redefine work paradigms,” said Sriniketh Chakravarthi, Chief Executive Officer, Apexon. “This study has unearthed crucial insights for regulated industries aiming to harness Gen AI’s true potential. The findings underscore the importance of an effective AI governance program, a human-in-the-loop approach to manage accuracy risks and the pivot employees will make from routine to more strategic and creative elements of their work.”
Apexon’s Gen AI capabilities:
Specializing in customized Gen AI solutions, Apexon addresses unique organizational needs and industry challenges by leveraging deep industry domain knowledge and advanced AI/ML expertise to design contextualized, human-centric applications that drive real-world outcomes. Genysys, a proprietary platform by Apexon, combines over 10+ LLM models into a versatile platform, streamlining content creation and workflow while ensuring fast processing and minimal latency. It unlocks Generative AI’s full potential for innovative, tailored content, enhancing operational efficiency and engagement. 
Click here to download the full study, titled “Regulated Industries Are Making Generative AI Core to Their Digital Strategy,” and discover more insights.
About Apexon:
Apexon is a digital-first technology services firm specializing in accelerating business transformation and delivering human-centric digital experiences. For over 17 years, the company has been meeting clients wherever they are in the digital lifecycle and helping them outperform their competition through speed and innovation. Its reputation is built on a comprehensive suite of engineering services, a dedication to solving clients’ toughest technology problems, and a commitment to continuous improvement. The company focuses on three broad solution areas of digital services: Digital Experience, Data Services, and Digital Engineering and has deep expertise in BFSI, healthcare, and life sciences. Apexon is backed by Goldman Sachs Asset Management and Everstone Capital.
Learn how Apexon helps clients with their digital transformation journeys at www.apexon.com.
Logo: https://mma.prnewswire.com/media/2263554/4375910/Apexon_Logo.jpg
Media contact:[email protected] 

View original content:https://www.prnewswire.co.uk/news-releases/new-independent-study-shows-70-of-organizations-prioritize-gen-ai-for-boosting-employee-productivity-302130442.html

Continue Reading

Artificial Intelligence

Droit and FINBOURNE Partner to Deliver End-to-End Position Reporting Solution

Published

on

droit-and-finbourne-partner-to-deliver-end-to-end-position-reporting-solution

LONDON, April 30, 2024 /PRNewswire/ — Droit, a technology firm at the forefront of computational law and regulation, will partner with FINBOURNE Technology, a provider of cloud-based investment data management software, to launch an end-to-end position reporting solution for increased regulatory transparency.

Over one hundred global jurisdictions have position reporting obligations, requiring market participants to report equity and equity derivatives holdings to regulatory bodies; a process that is complex, time consuming and costly.
Droit and FINBOURNE come together to deliver a joint, full-stack solution to enable sell-side and buy-side institutions to manage disclosure obligations for long, short and takeover panel reporting. This new offering leverages FINBOURNE’s financial data management platform LUSID, embedded with Droit’s Position Reporting product which delivers clear determination of reporting obligations based on consensus interpretations of requirements from Endoxa, a consortium of six global financial institutions. 
The unified approach ensures consistency around complex regulatory interpretations, regulatory clarity and accuracy of reporting. As part of the joint solution, Droit translates and processes detailed guidelines from all major global jurisdictions, automating the decision-making process for shareholder disclosure reporting eligibility. For complete accountability, a traceable audit record is generated for each evaluated position.
With FINBOURNE’s advanced data transformation capabilities, the new end-to-end solution seamlessly maps the multiple data inputs needed to evaluate rules. Moreover, it simplifies workflow interactions via an intuitive interface, effectively mitigating operational, cost, and complexity challenges.
“Integrating Droit into LUSID means that together we are able to deliver a complete solution for position reporting. This partnership enhances our ability to safeguard asset managers by making sense of shareholder disclosure data when it comes to complex trading books and provide a level of granular reporting detail that is unmatched in the industry.” added Thomas McHugh, CEO and Co-founder, FINBOURNE Technology.
“By partnering with FINBOURNE, we are able to leverage consensus interpretation and industry best practice for position reporting for all market participants.  The asset management industry can directly benefit from the experience of their sell-side counterparties.” said Brock Arnason, Founder and Chief Executive Officer of Droit. “FINBOURNE’s platform, built specifically to support the volume and complexity of data that characterizes position reporting, integrated with our consensus-driven eligibility rules, offers firms unrivaled traceability, transparency, and auditability.”
About Droit
Droit is a technology firm at the forefront of computational law and regulation within finance and other domains. Founded in 2012, Droit counts many of the largest financial institutions as its clients. Its award-winning, patented platform Adept provides an implementation of regulatory rules reflecting industry consensus. The Adept platform processes tens of millions of inquiries a day, deciding in real-time which interactions are legally permissible across the globe. Adept is used by institutions to evaluate, with sub-millisecond latency, the full regulatory implications of any given interaction within their transactional infrastructure.
For more information visit droit.tech. To obtain more information about Droit’s products, please contact [email protected].
About FINBOURNE Technology 
FINBOURNE combines extensive technical expertise in financial services data management with a best-in-class, open, cloud–based investment management and servicing product ecosystem. By deploying our solutions, our clients can better aggregate, manage and utilise data across their organisations.
With operations across North America, Europe, Asia and Australia, FINBOURNE’s data management solutions help financial services firms improve their investment management and servicing capabilities.
FINBOURNE is trusted by some of the world’s leading financial services firms, including Fidelity International, London Stock Exchange Group, Baillie Gifford and Northern Trust. 
For more information on FINBOURNE Technology visit www.FINBOURNE.com or contact [email protected] 
Logo – https://mma.prnewswire.com/media/2016603/Droit_Logo.jpgLogo – https://mma.prnewswire.com/media/2400551/Finbourne_logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/droit-and-finbourne-partner-to-deliver-end-to-end-position-reporting-solution-302130494.html

Continue Reading
Advertisement
Advertisement

Latest News

Trending